CRISPR Therapeutics AG (CRSP)
45.18
+1.33 (+3.03%)
USD |
NASDAQ |
Mar 29, 16:00
45.30
+0.12 (+0.27%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap: 3.553B for March 29, 2023
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| March 29, 2023 | 3.553B |
| March 28, 2023 | 3.449B |
| March 27, 2023 | 3.488B |
| March 24, 2023 | 3.416B |
| March 23, 2023 | 3.393B |
| March 22, 2023 | 3.424B |
| March 21, 2023 | 3.544B |
| March 20, 2023 | 3.497B |
| March 17, 2023 | 3.597B |
| March 16, 2023 | 3.570B |
| March 15, 2023 | 3.533B |
| March 14, 2023 | 3.551B |
| March 13, 2023 | 3.596B |
| March 10, 2023 | 3.399B |
| March 09, 2023 | 3.601B |
| March 08, 2023 | 3.770B |
| March 07, 2023 | 3.762B |
| March 06, 2023 | 3.880B |
| March 03, 2023 | 3.998B |
| March 02, 2023 | 3.869B |
| March 01, 2023 | 3.753B |
| February 28, 2023 | 3.879B |
| February 27, 2023 | 3.866B |
| February 24, 2023 | 3.777B |
| February 23, 2023 | 3.935B |
| Date | Value |
|---|---|
| February 22, 2023 | 3.962B |
| February 21, 2023 | 3.667B |
| February 17, 2023 | 4.002B |
| February 16, 2023 | 3.975B |
| February 15, 2023 | 4.096B |
| February 14, 2023 | 3.994B |
| February 13, 2023 | 4.044B |
| February 10, 2023 | 3.908B |
| February 09, 2023 | 4.010B |
| February 08, 2023 | 4.192B |
| February 07, 2023 | 4.370B |
| February 06, 2023 | 4.358B |
| February 03, 2023 | 4.339B |
| February 02, 2023 | 4.406B |
| February 01, 2023 | 4.109B |
| January 31, 2023 | 4.006B |
| January 30, 2023 | 3.922B |
| January 27, 2023 | 4.144B |
| January 26, 2023 | 3.963B |
| January 25, 2023 | 3.985B |
| January 24, 2023 | 4.080B |
| January 23, 2023 | 4.029B |
| January 20, 2023 | 3.895B |
| January 19, 2023 | 3.743B |
| January 18, 2023 | 3.969B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.184B
Minimum
Dec 21 2018
15.53B
Maximum
Jan 14 2021
4.896B
Average
4.074B
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 80.79B |
| Intellia Therapeutics Inc | 3.306B |
| Beam Therapeutics Inc | 2.246B |
| Moderna Inc | 57.39B |
| Editas Medicine Inc | 511.07M |
Market Cap Related Metrics
| PS Ratio | 8056.14 |
| Price to Book Value | 1.895 |
| Price | 45.18 |
| Earnings Yield | -18.53% |